Results 41 to 50 of about 165,916 (287)

Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report

open access: yesFrontiers in Psychiatry, 2023
BackgroundSerotonin syndrome has been recognized as a serious adverse reaction to antidepressants and is characterized by sudden or severe autonomic nerve dysfunction and neuromuscular symptoms.
Jianhong Wu   +11 more
doaj   +1 more source

Fluoxetine: a case history of its discovery and preclinical development [PDF]

open access: yes, 2014
Introduction: Depression is a multifactorial mood disorder with a high prevalence worldwide. Until now, treatments for depression have focused on the inhibition of monoaminergic reuptake sites, which augment the bioavailability of monoamines in the CNS ...
Bel N   +20 more
core   +2 more sources

Serotonin and the carcinoid syndrome [PDF]

open access: yesCanadian Anaesthetists’ Society Journal, 1959
A brief description of some of the main physiological actions of serotonin has been given. Their clinical implications, especially where they pertain to the field of anaesthesia, are presented in some detail. The malignant carcinoid syndrome is discussed and some of the problems which may confront the anaesthesiologist in dealing with patients ...
openaire   +2 more sources

Serotonin Syndrome in Critical Care

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2023
Serotonin syndrome is a life-threatening syndrome that can occur when medications or drugs that cause serotonergic activity are taken. Frequently this syndrome is caused using 2 serotonergic medications at once or switching from 1 serotonergic medication
Daniel Miller DO   +4 more
doaj   +1 more source

5-hydroxytryptamine (5-HT) cellular sequestration during chronic exposure delays 5-HT3 receptor resensitization due to Its subsequent release [PDF]

open access: yes, 2014
The serotonergic synapse is dynamically regulated by serotonin (5-hydroxytryptamine (5-HT)) with elevated levels leading to the down-regulation of the serotonin transporter and a variety of 5-HT receptors, including the 5-HT type-3 (5-HT(3)) receptors ...
Aapro   +54 more
core   +3 more sources

Serotonin syndrome: a rare undiagnosed cause of hyperpyrexia

open access: yesThe Egyptian Journal of Internal Medicine, 2023
Serotonin syndrome (SS) is a rare but potentially life-threatening condition, and it is caused by increasing serotonergic activities. It is an underdiagnosed and under-reported condition.
Hamdy Ibrahim   +8 more
doaj   +1 more source

Management of Widespread Pain and Fibromyalgia [PDF]

open access: yes, 2016
Peer reviewedPublisher ...
Basu, Neil   +2 more
core   +2 more sources

Delayed onset serotonin syndrome in the setting of polypharmacy

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2021
Serotonin syndrome is a rare but well-known condition that can be life-threatening if not diagnosed early. Onset is usually within 4 to 13 h of starting the offending medication.
Roshan Acharya   +4 more
doaj   +1 more source

Duodenal carcinoid tumour – a case report [PDF]

open access: yes, 2020
Duodenal carcinoids are rare tumours of the small intestine with heterogenous clinical and pathological characteristics. The long-term prognosis is very good if discovered in the early stages.
Alexescu, Teodora Gabriela   +7 more
core   +2 more sources

Serotonin: beyond menopause [PDF]

open access: yesRomanian Journal of Medical Practice, 2016
Serotonin is a brain neurotransmitter, a local gut-produced pro-kinetic agent and a platelets-released monoamine with haemostasis role. We focus on revealing the serotonin interferences with menopause mainly related to climacteric syndrome and bone ...
Mara Carsote   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy